Pfizer completes acquisition of Metsera for USD 7 billion to expand obesity and cardiometabolic… EP News Bureau Nov 14, 2025 The deal adds multiple clinical-stage candidates, including GLP-1 and amylin assets, as Metsera becomes a wholly owned Pfizer…
